What to expect when you take Breo ellipta and have Saliva analysis abnormal?

Do you take Breo ellipta and have Saliva analysis abnormal? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Jun, 22, 2018

450 reports have been studied.


Females aged 50 to 59 :

303 related reports were analyzed:

Most common symptoms:

Chest pain
  • 6.27% for females aged 50 (±5) who take Breo ellipta
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  • 7.26% for females aged 50 (±5) who take Breo ellipta
Cough
  • 6.93% for females aged 50 (±5) who take Breo ellipta
Drug ineffective
  • 12.87% for females aged 50 (±5) who take Breo ellipta
Dyspnea (difficult or laboured breathing)
  • 11.55% for females aged 50 (±5) who take Breo ellipta
Fatigue (feeling of tiredness)
  • 6.6% for females aged 50 (±5) who take Breo ellipta
Headache (pain in head)
  • 6.27% for females aged 50 (±5) who take Breo ellipta
Malaise (a feeling of general discomfort or uneasiness)
  • 5.61% for females aged 50 (±5) who take Breo ellipta
Pneumonia
  • 6.93% for females aged 50 (±5) who take Breo ellipta
Weakness
  • 5.61% for females aged 50 (±5) who take Breo ellipta

Most common co-existing conditions:

Depression
  • 5.28% for females aged 50 (±5) who take Breo ellipta
Gastroesophageal reflux disease (a condition in which stomach contents leak backward from the stomach into the oesophagus)
  • 6.27% for females aged 50 (±5) who take Breo ellipta
High blood pressure
  • 5.61% for females aged 50 (±5) who take Breo ellipta
back to top

Males aged 50 to 59 :

147 related reports were analyzed:

Most common symptoms:

Chest pain
  • 7.48% for males aged 50 (±5) who take Breo ellipta
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  • 9.52% for males aged 50 (±5) who take Breo ellipta
Cough
  • 6.12% for males aged 50 (±5) who take Breo ellipta
Drug ineffective
  • 13.61% for males aged 50 (±5) who take Breo ellipta
Dyspnea (difficult or laboured breathing)
  • 17.01% for males aged 50 (±5) who take Breo ellipta
Fatigue (feeling of tiredness)
  • 6.12% for males aged 50 (±5) who take Breo ellipta
Pneumonia
  • 5.44% for males aged 50 (±5) who take Breo ellipta

Most common co-existing conditions:

Dyspnea (difficult or laboured breathing)
  • 6.12% for males aged 50 (±5) who take Breo ellipta
High blood pressure
  • 8.84% for males aged 50 (±5) who take Breo ellipta
back to top

Related studies

breo ellipta

Breo ellipta has active ingredients of fluticasone furoate; vilanterol trifenatate. It is often used in chronic obstructive pulmonary disease. (latest outcomes from Breo ellipta 6,116 users)

saliva analysis abnormal

Saliva analysis abnormal has been reported by people with hypothyroidism, epilepsy, stress and anxiety, hyperthyroidism, blood testosterone increased (latest reports from 5 Saliva analysis abnormal patients).

Breo ellipta and Saliva analysis abnormal

Analysis tools (to study 615 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Breo ellipta, Saliva analysis abnormal

Recent updates

General studies
Active Support Groups
Recent Predictions
Care Guides wanted

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.